Case number 1:22-cv-01467
Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 17, 2023 | 41 | ORAL ORDER: In light of the Consolidation Order, (D.I. 29 in Civil Action No. 22-1461), entered by District Judge Colm F. Connolly, designating Civil Action No. 22-1461 as the lead case of the related actions, including Civil Action No. 22-1467, the Court hereby ORDERS that Plaintiffs' Motion to Strike, (D.I. 28 in Civil Action No. 22-1467), is DENIED, as it has been superseded by Plaintiffs' Renewed Motion to Strike, (D.I. 66 in Civil Action No. 22-1461). Ordered by Judge Christopher J. Burke on 10/17/2023. (dlb) (Entered: 10/17/2023) (0) |
| Jun 6, 2023 | 40 | CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. Case reassigned to Magistrate Judge Christopher J. Burke. Signed by Judge Colm F. Connolly on 6/6/2023. (nmf) (Entered: 06/06/2023) (1) |
| May 23, 2023 | 39 | NOTICE OF SERVICE of 1) Plaintiffs' First Set of Requests to Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. for the Production of Documents and Things and 2) Plaintiffs' First Set of Interrogatories to Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 05/23/2023) (2) |
| May 19, 2023 | 38 | SCHEDULING & CONSOLIDATION ORDER: CIVIL ACTION NO. 22-1461-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CASE ONLY. Joinder of Parties due by 3/28/2024. Amended Pleadings due by 3/28/2024. Fact Discovery completed by 6/27/2024. Expert Discovery due by 1/16/2025. Joint Claim Construction Brief due by 3/7/2024. A Markman Hearing is set for 5/1/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 3/5/2025. A Final Pretrial Conference is set for 3/26/2025 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/7/2025 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/18/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 05/19/2023) (30) |
| May 15, 2023 | 37 | PROPOSED ORDER // [Proposed] Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A)(Stover, Chad) (Entered: 05/15/2023) (Main Document) (26) |
| May 15, 2023 | 37 | PROPOSED ORDER // [Proposed] Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A)(Stover, Chad) (Entered: 05/15/2023) (Exhibit A) (4) |
| May 9, 2023 | 36 | Official Transcript of In-Person Scheduling Conference held on May 8, 2023 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: Bonnie_Archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/30/2023. Redacted Transcript Deadline set for 6/9/2023. Release of Transcript Restriction set for 8/7/2023. (nmf) (Entered: 05/09/2023) (0) |
| Apr 18, 2023 | 35 | PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Letter regarding Proposed Scheduling Order)(Stover, Chad) (Entered: 04/18/2023) (Main Document) (30) |
| Apr 18, 2023 | 35 | PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Letter regarding Proposed Scheduling Order)(Stover, Chad) (Entered: 04/18/2023) (Letter regarding Proposed Scheduling Order) (2) |
| Apr 7, 2023 | 34 | STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 04/07/2023) (3) |
| Mar 3, 2023 | 32 | REPLY BRIEF re 28 MOTION to Strike 20 Answer to Amended Complaint // Motion to Strike Defendants' Affirmative Defense Nos. 2, 5 and Defendants' Improper Denials filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 03/03/2023) (17) |
| Mar 3, 2023 | 33 | REQUEST for Oral Argument by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. re 28 MOTION to Strike 20 Answer to Amended Complaint // Motion to Strike Defendants' Affirmative Defense Nos. 2, 5 and Defendants' Improper Denials. (Stover, Chad) (Entered: 03/03/2023) (2) |
| Feb 24, 2023 | 31 | ANSWERING BRIEF in Opposition re 28 MOTION to Strike 20 Answer to Amended Complaint // Motion to Strike Defendants' Affirmative Defense Nos. 2, 5 and Defendants' Improper Denials filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..Reply Brief due date per Local Rules is 3/3/2023. (Myer, R.) (Entered: 02/24/2023) (11) |
| Feb 13, 2023 | 30 | DEFICIENCY NOTICE by the Court issued to Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. re 29 Opening Brief in Support. Pursuant to the Court's Standing Order Regarding Briefing in All Cases, dated November 10, 2022, "[t]he covers of briefs filed in connection with all motions except for motions in limine included in a pretrial order shall be as follows: i. Opening Brief Blue; ii. Answering Brief Red; iii. Reply Brief Gray." Courtesy copies of D.I. 29 are not in compliance with the Court's standing order. Please resubmit courtesy copies of your brief with the corrected covers. (kmd) (Entered: 02/13/2023) (2) |
| Feb 10, 2023 | 27 | Letter to The Honorable Colm F. Connolly from Chad S.C. Stover regarding coordinated discovery and Markman proceedings - re (14 in 1:22-cv-01462-CFC, 14 in 1:22-cv-01462-CFC, 22 in 1:22-cv-01465-CFC, 22 in 1:22-cv-01465-CFC, 14 in 1:22-cv-01461-CFC, 14 in 1:22-cv-01461-CFC, 18 in 1:22-cv-01467-CFC, 18 in 1:22-cv-01467-CFC) Order,,, Set Deadlines,,. (Stover, Chad) (Entered: 02/10/2023) (2) |
| Feb 10, 2023 | 28 | MOTION to Strike 20 Answer to Amended Complaint // Motion to Strike Defendants' Affirmative Defense Nos. 2, 5 and Defendants' Improper Denials - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Text of Proposed Order)(Stover, Chad) (Entered: 02/10/2023) (Main Document) (3) |
| Feb 10, 2023 | 29 | OPENING BRIEF in Support re 28 MOTION to Strike 20 Answer to Amended Complaint // Motion to Strike Defendants' Affirmative Defense Nos. 2, 5 and Defendants' Improper Denials filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 2/24/2023. (Stover, Chad) (Entered: 02/10/2023) (21) |
| Feb 10, 2023 | 28 | MOTION to Strike 20 Answer to Amended Complaint // Motion to Strike Defendants' Affirmative Defense Nos. 2, 5 and Defendants' Improper Denials - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Text of Proposed Order)(Stover, Chad) (Entered: 02/10/2023) (Text of Proposed Order) (2) |
| Jan 23, 2023 | 25 | SO ORDERED, re 22 STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,251,873, 10,471,053, 10,792,278, 10,799,491, 10,857,141, 10,857,142, and 10,874,656. Signed by Judge Colm F. Connolly on 1/23/2023. (nmf) (Entered: 01/23/2023) (6) |
| Jan 23, 2023 | 26 | SO ORDERED, re 23 STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,076,514 and 11,234,972. Signed by Judge Colm F. Connolly on 1/23/2023. (nmf) (Entered: 01/23/2023) (5) |
| Jan 20, 2023 | 20 | ANSWER to Amended Complaint, re: 15 Amended Complaint by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 01/20/2023) (30) |
| Jan 20, 2023 | 21 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 01/20/2023) (2) |
| Jan 20, 2023 | 22 | STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,251,873, 10,471,053, 10,792,278, 10,799,491, 10,857,141, 10,857,142, and 10,874,656 by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/20/2023) (6) |
| Jan 20, 2023 | 23 | STIPULATION and Covenant Not to Sue re: U.S. Patent Nos. 10,076,514 and 11,234,972 by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/20/2023) (5) |
| Jan 20, 2023 | 24 | MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 01/20/2023) (3) |
| Jan 19, 2023 | 19 | MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/19/2023) (4) |
| Jan 12, 2023 | 18 | ORDER, IT IS ORDERED that, on or before February 10, 2023, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to these cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/10/2023.) Signed by Judge Colm F. Connolly on 1/12/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 01/12/2023) (3) |
| Jan 6, 2023 | 16 | STIPULATION TO EXTEND TIME for Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. to Answer the First Amended Complaint to January 20, 2023 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 01/06/2023) (4) |
| Jan 6, 2023 | 17 | NOTICE OF SERVICE of Production of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch-Waxman Cases in Which Infringement is Alleged filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Myer, R.) (Entered: 01/06/2023) (2) |
| Dec 21, 2022 | 15 | Amended Complaint* (1) |
